Pulmonx (LUNG) Accounts Payables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Accounts Payables data on file, last reported at $3.9 million in Q4 2025.

• Quarterly Accounts Payables rose 2.04% year-over-year to $3.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.9 million (up 2.04% YoY) and the FY2025 annual result came in at $3.9 million, up 2.04% from the prior year.
• Accounts Payables retreated to $3.9 million in Q4 2025 per LUNG's latest filing, from $6.4 million in the prior quarter.
• Across five years, Accounts Payables topped out at $6.6 million in Q2 2025 and bottomed at $1.5 million in Q4 2023.
• The 5-year median for Accounts Payables is $3.0 million (2023), against an average of $3.3 million.
• The widest annual swing landed in 2022, when Accounts Payables plunged 40.28%; it then jumped 155.64% in 2024.
• Tracing LUNG's Accounts Payables over 5 years: stood at $1.6 million in 2021, then rose by 11.13% to $1.8 million in 2022, then declined by 14.85% to $1.5 million in 2023, then jumped by 155.64% to $3.8 million in 2024, then grew by 2.04% to $3.9 million in 2025.
• Per Business Quant, the three latest LUNG Accounts Payables figures stand at $3.9 million (Q4 2025), $6.4 million (Q3 2025), and $6.6 million (Q2 2025).

Peer Comparison